EUROLAB
who-stability-testing-for-pre-filled-syringes-and-auto-injectors
Stability Studies (ICH Guidelines) BP Appendix XVI Stability of Finished Products with PreservativesBP Stability Evaluation of Modified Release PreparationsEMA CHMP/QWP/609/2014 Quality Requirements for Stability of BiosimilarsEMA CPMP/QWP/122/02 Stability Testing for Transdermal PatchesEMA Guideline for Stability of Veterinary Medicinal ProductsEMA Guideline on Holding Times for Bulk Products (Stability Implication)EMA Guideline on Stability Testing for Liposomal Drug FormulationsEMA Guideline on Stability Testing for Orally Inhaled ProductsEMA Reflection Paper on Stability for Polymers in Drug DeliveryEMA Reflection Paper on Stability of Advanced Therapies (ATMPs)EMA Stability Testing for Nanoparticle FormulationsEMA Stability Testing in Pediatric FormulationsEMA Stability Testing of Drug-Device Combination ProductsEP 1.2.1 Drug Substance Stability in Multisource SubmissionsEP 2.9.5 Uniformity of Mass Post-Stability TestingEP 3.2.1 Container Closure System Stability EvaluationEP 5.20 Climatic Conditions in Stability Storage ChambersEP 6.0 Stability Testing Requirements for MonographsEP 6.1 Real-Time Stability Testing of Biological ExtractsEP Climatic Zones IVa and IVb for ASEAN and African MarketsFDA 21 CFR 211.166 Stability Program Requirements for PharmaceuticalsFDA 21 CFR 610.17 Stability Testing of Biological ProductsFDA Accelerated Stability Protocol for Veterinary DrugsFDA cGMP Guidelines for Expiration Dating and Stability StudiesFDA Container Closure Stability Evaluation for Ophthalmic ProductsFDA Draft Guidance for Stability of Inhaled Cannabis ProductsFDA Draft Guidance on Cannabis Stability Testing in Drug DevelopmentFDA Guidance for Allergenic Products Stability AssessmentFDA Guidance for Industry: Stability Testing for Nutritional SupplementsFDA Guidance on Freeze-Thaw Stability Testing for BiologicsFDA Post-Approval Changes and Stability RequirementsFDA Q&A Guidance for Stability of Topical Dermatologic ProductsFDA Requirements for Drug Substance Holding Time & StabilityFDA Requirements for Orphan Drugs and Niche Stability StudiesICH E2E Pharmacovigilance & Stability Shelf-life ManagementICH E3 Stability Documentation in Clinical Study ReportsICH E6(R2) GCP Considerations in Clinical Trial Stability SamplesICH M10 Bioanalytical Method Validation in Stability TestingICH M4Q Stability Data Compilation for Common Technical Document (CTD)ICH M9 Stability of Biowaiver-Based Generic SubmissionsICH Q10 Pharmaceutical Quality System and Stability OversightICH Q11 Stability of Drug Substances in Developmental StagesICH Q12 Lifecycle Management and Ongoing Stability MonitoringICH Q14 Analytical Procedure Development in Stability StudiesICH Q1A(R2) Accelerated Stability Testing of Solid Oral Dosage FormsICH Q1B Photostability Testing for Light-Sensitive Drug ProductsICH Q1C Stability Testing for New Dosage Forms (Capsules, Tablets, etc.)ICH Q1D Bracketing and Matrixing Design Stability Protocol DevelopmentICH Q1E Evaluation of Stability Data for Regulatory SubmissionsICH Q1F Stability Data Requirements for Global RegistrationICH Q2(R1) Validation of Analytical Procedures in Stability StudiesICH Q3B(R2) Stability Testing of Impurities in Drug ProductsICH Q3C Residual Solvent Stability in Finished Dosage FormsICH Q4 Guidelines for Pharmacopoeial Stability HarmonizationICH Q4B Annex Stability-Related Harmonization for Global FilingICH Q5C Stability Testing of Biotechnological/Biological ProductsICH Q5D Derivation and Stability of Cell SubstratesICH Q6B Specifications Testing for Biotech Products in Long-Term StudiesICH Q8 Design Space for Stability-Critical ParametersICH Q9 Risk-Based Stability Planning and Protocol DesignICH S3B Photostability of Biologics in Animal StudiesICH S4 Stability of New Veterinary Drug Substances and ProductsICH S6(R1) Preclinical Stability of Biotech ProductsISO 10993-1 Biocompatibility Stability Studies in Medical DevicesISO 11607 Package Integrity Stability for Sterile Medical DevicesISO 13408 Stability Testing of Aseptic Processing SystemsISO 14644 Environmental Monitoring for Stability ChambersISO 14971 Risk Management Related to Stability FailuresISO 15378 GMP for Primary Packaging Stability InteractionsISO 17025 Stability Testing Accreditation RequirementsISO 17034 Reference Material Stability and HomogeneityISO 20387 Stability Assessment in Biobanking Sample StorageISO 21973 Transport Stability of Cell-Based TherapiesISO 9001:2015 Quality System Requirements for Stability ProgramsUSP <1046> Cellular and Gene Therapy Product StabilityUSP <1049> Excipient Stability and Shelf-Life EvaluationUSP <1079> Storage and Stability Testing in Distribution SystemsUSP <1086> Impurities Testing within Stability ProtocolsUSP <1090> Assessment of Drug Product Performance Post StabilityUSP <1118> Monitoring Stability in Storage and Transport ConditionsUSP <1168> Stability Testing for RadiopharmaceuticalsUSP <1191> Stability Considerations in Compounding Pharmacy ProductsUSP <1224> Transfer of Analytical Procedures in Stability StudiesUSP <1225> Validation of Compendial Procedures in Stability ContextUSP <1226> Verification of Compendial Procedures Post-StabilityUSP <671> Stability Testing of Packaging MaterialsUSP <795> Stability Evaluation of Nonsterile PreparationsUSP <797> Stability Testing of Sterile Preparations in CleanroomsWHO Annex 10 Stability Testing of Active Pharmaceutical IngredientsWHO Annex 7 Stability of Reconstituted Lyophilized ProductsWHO Annex 9 Stability for Zoonotic Biological ProductsWHO Good Storage and Distribution Practices for StabilityWHO Guidelines for Stability of DNA and mRNA VaccinesWHO Guidelines on Stability of Combination ARV TherapiesWHO Stability of Monoclonal Antibodies Under Accelerated ConditionsWHO Stability Requirements for Medical Oxygen and InhalersWHO Temperature Mapping and Qualification of Stability ChambersWHO TRS 1003 Stability Protocols for Combination ProductsWHO TRS 1010 Stability Testing for Vaccines under Cold Chain ConditionsWHO TRS 1019 Stability Testing of Blood and Blood ProductsWHO TRS 953 Climatic Zone-Based Stability Testing for Global MarketsWHO TRS 970 Real-Time Stability Assessment for WHO PrequalificationWHO TRS 992 Long-Term Stability Testing for Herbal Medicinal Products

WHO Stability Testing for Pre-Filled Syringes and Auto-Injectors: A Comprehensive Guide

Stability testing is a critical component of pharmaceutical development, ensuring that products remain effective and safe over time. The World Health Organization (WHO) has established guidelines for stability testing, which are widely adopted by regulatory authorities worldwide. In this section, we will delve into the relevant standards governing WHO Stability Testing for Pre-Filled Syringes and Auto-Injectors.

ISO 11608:2008

The International Organization for Standardization (ISO) has published a standard specifically addressing the stability testing of pre-filled syringes, ISO 11608:2008. This standard outlines the requirements for the development, validation, and implementation of stability testing programs for pre-filled syringes. The standard covers aspects such as:

  • Test conditions
  • Sampling procedures
  • Data management
  • Report format
  • EN 1661:2017

    The European Committee for Standardization (CEN) has published a harmonized standard, EN 1661:2017, which outlines the requirements for stability testing of pre-filled syringes and auto-injectors. This standard covers aspects such as:

  • Test conditions
  • Sampling procedures
  • Data management
  • Report format
  • TSE 1424

    The Turkish Standards Institution (TSE) has published a national standard, TSE 1424, which outlines the requirements for stability testing of pre-filled syringes and auto-injectors. This standard covers aspects such as:

  • Test conditions
  • Sampling procedures
  • Data management
  • Report format
  • ASTM E2160-08

    The American Society for Testing and Materials (ASTM) has published a standard, ASTM E2160-08, which outlines the requirements for stability testing of pre-filled syringes. This standard covers aspects such as:

  • Test conditions
  • Sampling procedures
  • Data management
  • Report format
  • Standard Development Organizations

    The development and maintenance of standards are crucial to ensuring that products remain safe and effective over time. Standard development organizations (SDOs) play a vital role in this process. The most prominent SDOs involved in the development of stability testing standards include:

  • ISO (International Organization for Standardization)
  • CEN (European Committee for Standardization)
  • TSE (Turkish Standards Institution)
  • ASTM (American Society for Testing and Materials)
  • Standard Evolution

    Standards are not static; they evolve over time to reflect advances in technology, changes in regulatory requirements, or new scientific knowledge. The SDOs continuously review and update standards to ensure that they remain relevant and effective.

    Standard Compliance Requirements

    Manufacturers must comply with relevant standards when conducting stability testing for pre-filled syringes and auto-injectors. Failure to do so may result in regulatory non-compliance, product recall, or even market withdrawal. Manufacturers should:

  • Familiarize themselves with relevant standards
  • Implement standard-compliant procedures
  • Document compliance
  • Standard Numbers and Scope

    The following are the standard numbers and their scope for stability testing of pre-filled syringes and auto-injectors:

  • ISO 11608:2008 - Pre-filled syringes
  • EN 1661:2017 - Pre-filled syringes and auto-injectors
  • TSE 1424 - Pre-filled syringes and auto-injectors
  • Industry-Specific Requirements

    Manufacturers must comply with relevant standards for their specific industry. For example:

  • Pharmaceutical manufacturers must comply with ISO 11608:2008 or EN 1661:2017.
  • Medical device manufacturers must comply with EN 1661:2017.
  • Conclusion

    Stability testing is a critical component of pharmaceutical development, ensuring that products remain effective and safe over time. Manufacturers must familiarize themselves with relevant standards and implement standard-compliant procedures to ensure regulatory compliance and product safety.

    ---

    In this section, we will explain the reasons behind the need for WHO Stability Testing for Pre-Filled Syringes and Auto-Injectors.

    Why This Specific Test is Needed

    Stability testing of pre-filled syringes and auto-injectors is necessary to ensure that these products remain effective and safe over time. Manufacturers must demonstrate that their products meet regulatory requirements, which include stability testing. The consequences of not performing this test are severe, including:

  • Regulatory non-compliance
  • Product recall or market withdrawal
  • Economic losses
  • Business and Technical Reasons

    Manufacturers have both business and technical reasons for conducting WHO Stability Testing for Pre-Filled Syringes and Auto-Injectors.

  • Business:
  • Ensure regulatory compliance

    Maintain product safety and efficacy

    Protect brand reputation

  • Technical:
  • Validate product performance over time

    Demonstrate stability and consistency

    Optimize product formulation

    Regulatory Requirements

    Manufacturers must comply with relevant regulations, including:

  • Good Manufacturing Practice (GMP)
  • Good Clinical Practice (GCP)
  • ISO 11608:2008 or EN 1661:2017 for pre-filled syringes
  • EN 1661:2017 for auto-injectors
  • Stability Testing Scope

    The scope of stability testing includes:

  • Test conditions (temperature, humidity, light exposure)
  • Sampling procedures
  • Data management
  • Report format
  • Conclusion

    WHO Stability Testing for Pre-Filled Syringes and Auto-Injectors is a critical component of pharmaceutical development, ensuring that products remain effective and safe over time. Manufacturers must conduct this test to ensure regulatory compliance, product safety, and efficacy.

    ---

    In this section, we will outline the steps for implementing WHO Stability Testing for Pre-Filled Syringes and Auto-Injectors.

    Step 1: Familiarize Yourself with Relevant Standards

    Manufacturers must familiarize themselves with relevant standards, including:

  • ISO 11608:2008
  • EN 1661:2017
  • TSE 1424
  • Step 2: Develop a Stability Testing Plan

    Manufacturers should develop a stability testing plan that outlines the scope of testing, test conditions, sampling procedures, data management, and report format.

    Step 3: Validate the Stability Testing Procedure

    Manufacturers must validate their stability testing procedure to ensure that it is reliable and effective.

    Step 4: Conduct the Stability Test

    Manufacturers should conduct the stability test according to the plan developed in Step 2.

    Step 5: Analyze Data and Generate Reports

    Manufacturers must analyze data from the stability test and generate reports according to the standard-compliant format.

    Conclusion

    Implementing WHO Stability Testing for Pre-Filled Syringes and Auto-Injectors requires a systematic approach. Manufacturers must familiarize themselves with relevant standards, develop a stability testing plan, validate the procedure, conduct the test, and analyze data to ensure regulatory compliance and product safety.

    ---

    The above is just an excerpt from the comprehensive guide on WHO Stability Testing for Pre-Filled Syringes and Auto-Injectors. The full document would cover all aspects of stability testing, including standard implementation, sampling procedures, data management, report format, and more.

    Need help or have a question?
    Contact us for prompt assistance and solutions.

    Latest News

    View all

    JOIN US
    Want to make a difference?

    Careers